SciELO - Scientific Electronic Library Online

vol.18 número2Características personales, clínicas y sociales en pacientes con estancia hospitalaria prolongada en los pabellones de pacientes agudos del Hospital Víctor Larco HerreraTumor sólido pseudopapilar de páncreas: Tumor de Frantz índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Horizonte Médico (Lima)

versión impresa ISSN 1727-558X


SANDOVAL PAREDES, José  y  SANDOVAL PAZ, Cindy. Drug use during pregnancy. Horiz. Med. [online]. 2018, vol.18, n.2, pp.71-79. ISSN 1727-558X.

There is plenty of information about drug safety during pregnancy, but there is little scientific evidence on this topic. Due to ethical reasons, very scarce clinical assays have been conducted and published. This situation has resulted in the exaggeration of drug risk during pregnancy, thus limiting its reasonable use for chronic diseases in pregnant women. At the other extreme, it has resulted in the careless prescription of drugs not acknowledging the real risk involved in administering them in the inappropriate dose and moment. This review article describes how physiological changes during pregnancy modify significantly the pharmacokinetics of drugs. The real potential risk of drug-induced teratogenesis and the specific criteria for considering them an etiological factor are evaluated. The U.S. Food and Drug Administration (FDA) pregnancy categories' criteria, limitations, and limited current validity are discussed, as well as its proposal of new regulations on drug labeling, considering clinical evaluations, unnoticed exposure, and risks. The risks associated with the most frequently used drugs for the most common diseases during pregnancy are described. The correct way to tell the patient exposed to suspected teratogens is discussed, in order to avoid affecting risk perception. It should be considered that the administration of the most frequently prescribed drugs is relatively safe during pregnancy. Nevertheless, only those strictly necessary must be prescribed, their consumption must be limited during the first trimester, those proven safety must be preferred, the minimum effective dose during the shortest time possible must be used, the administration of several drugs must be avoided, and side effects and complications must be monitored

Palabras clave : Pregnancy; drugs; teratogens; risk category.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons